Skip to main content

Table 1 Clinical pathological parameters of the UCEC patients included in this study

From: Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer

Characteristic

Level

Overall

n

 

552

Clinical stage, n (%)

Stage I

342 (62%)

Stage II

51 (9.2%)

Stage III

130 (23.6%)

Stage IV

29 (5.3%)

Primary therapy outcome, n (%)

PD

20 (4.2%)

SD

6 (1.2%)

PR

12 (2.5%)

CR

442 (92.1%)

Age, n (%)

≤ 60

206 (37.5%)

> 60

343 (62.5%)

BMI, n (%)

≤ 30

212 (40.8%)

> 30

307 (59.2%)

Histological type, n (%)

Endometrioid

410 (74.3%)

Mixed

24 (4.3%)

Serous

118 (21.4%)

Histologic grade, n (%)

G1

98 (18.1%)

G2

120 (22.2%)

G3

323 (59.7%)

OS event, n (%)

Alive

458 (83%)

Dead

94 (17%)

PFI event, n (%)

Alive

423 (76.6%)

Dead

129 (23.4%)

Diabetes, n (%)

No

328 (72.7%)

Yes

123 (27.3%)

Tumour invasion (%), n (%)

 < 50

259 (54.6%)

≥ 50

215 (45.4%)